NCT02192593

Brief Summary

This is a randomized controlled trial, examining the effects of a computerized, internet-based Cognitive Behavioral Therapy (CBT) Intervention for persons with a schizophrenia spectrum disorder who experience distressing auditory hallucinations (voices). Participants are randomized to one of two conditions: either to receive the 10-session computer-based program on a weekly basis, or to their usual care at their mental health clinic. This study takes place at Cambridge Health Alliance in Cambridge Massachusetts. It is hypothesized that the participants who participate in the CBT program will have significant improvements in the severity of their auditory hallucinations, as well as their associated distress, compared to the participants receiving usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

September 13, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
7 months until next milestone

First Posted

Study publicly available on registry

July 17, 2014

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

March 6, 2017

Status Verified

July 1, 2015

Enrollment Period

2.2 years

First QC Date

September 13, 2013

Last Update Submit

March 3, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Brief Psychiatric Rating Scale (BPRS)

    Primary outcome is change in BPRS hallucinations item from baseline to post-treatment to 3 month follow-up. This measure assesses severity of auditory hallucinations as well as overall psychiatric symptoms

    Baseline, Post-Treatment, 3-Month Follow-up

Study Arms (2)

Computer CBT

EXPERIMENTAL

A 10-session computerized cognitive-behavioral therapy intervention

Behavioral: Computer CBT

Usual Care

NO INTERVENTION

Interventions

Computer CBTBEHAVIORAL
Computer CBT

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be on a stable dose of antipsychotic medication for the past 3 months.
  • Schizophrenia-spectrum diagnosis, including schizophrenia, schizoaffective disorder, schizophreniform disorder, and psychosis, not otherwise specified.
  • At least moderate severity on Brief Psychiatric Rating Scale (BPRS) hallucinations item.
  • Naïve to CBTp for Auditory Hallucinations within the past 3 years.
  • No current suicidal ideation or hospitalization within the past month.
  • Reading level of at least 4th grade, as measured by the reading section of the Wide Range Achievement Test (WRAT)
  • Current patient receiving care at Cambridge Health Alliance

You may not qualify if:

  • Terminal physical illness expected to result in the death of the study participant within one year.
  • Primary diagnosis of dementia or a diagnosis of a psychiatric disorder secondary to a medical condition.
  • Comorbid dementia (severe cognitive impairment) as indicated by a Mini-mental state examination score \<24.
  • Current active substance abuse or dependence with the need for specialized substance abuse services
  • Does not speak English
  • Does not achieve a 4th grade reading level as demonstrated on the Wide Range Achievement Test (WRAT)
  • Has a legal guardian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cambridge Health Alliance

Cambridge, Massachusetts, 02139, United States

Location

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Jennifer D Gottlieb, PhD

    Boston University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

September 13, 2013

First Posted

July 17, 2014

Study Start

November 1, 2011

Primary Completion

January 1, 2014

Study Completion

February 1, 2015

Last Updated

March 6, 2017

Record last verified: 2015-07

Locations